I would like to know a little more about why Dr Fred Grossman left...
Mesoblast Chief Executive Dr. Silviu Itescu thanked outgoing CMO Dr. Fred Grossman for his
important contributions, particularly in regard to the regulatory progress of remestemcel-L in children
with steroid-refractory acute graft versus host disease (SR-aGVHD) and his role in the Company’s
pivot to COVID-19 acute respiratory distress syndrome. Dr. Grossman will continue to provide support
to the Company in an ongoing advisory role.
I would like to know a little more about why Dr Fred Grossman...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
-0.045(3.83%) |
Mkt cap ! $1.290B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.19 | $1.12 | $12.16M | 10.69M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 50650 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.14 | 124897 | 8 |
View Market Depth
| Last trade - 16.10pm 08/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.13 |
Change
-0.045 ( 4.33 %) |
||||
| Open | High | Low | Volume | ||
| $1.17 | $1.17 | $1.12 | 1447014 | ||
| Last updated 15.59pm 08/05/2024 ? | |||||
| MSB (ASX) Chart |